Imprimis NJOF, LLC: Drug Recall
Recall #D-0514-2024 · 05/14/2024
Class II: Risk
Recall Details
- Recall Number
- D-0514-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Imprimis NJOF, LLC
- Status
- Ongoing
- Date Initiated
- 05/14/2024
- Location
- Ledgewood, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 38,060 vials
Reason for Recall
Lack of Assurance of Sterility
Product Description
Dexamethasone-Moxifloxacin- Ketorolac (1mg/mL, 0.5 mg/mL and 0.4 mg/mL), Preservative-Free, 1mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01
Distribution Pattern
Nationwide within the United States
Other Recalls by Imprimis NJOF, LLC
- Class II: Risk 12/18/2025
- Class II: Risk 12/18/2025
- Class II: Risk 12/18/2025
- Class III: Low Risk 10/20/2025
- Class III: Low Risk 07/09/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.